Sisunatovir HCl

For research use only. Not for therapeutic Use.

  • CAT Number: I036317
  • CAS Number: 1903763-83-6
  • Molecular Formula: C23H23ClF4N4O
  • Molecular Weight: 482.91
  • Purity: 98%
Inquiry Now

Sisunatovir HCl(Cat No.:I036317)is a high-purity hydrochloride salt form of a potent respiratory syncytial virus (RSV) fusion inhibitor. It is widely used in antiviral research for its ability to block RSV replication by targeting the fusion protein, crucial for viral entry into host cells. This compound is instrumental in studying RSV pathogenesis and developing therapies for respiratory infections. Sisunatovir HCl’s efficacy and specificity make it a valuable tool in virology and pharmaceutical research, aiding the discovery of innovative treatments for RSV and related respiratory viral diseases.


Catalog Number I036317
CAS Number 1903763-83-6
Synonyms

RV521 hydrochloride; RV-521; RV 521; RV521; Sisunatovir HCl; Sisunatovir hydrochloride;

Molecular Formula C23H23ClF4N4O
Purity 98%
Target RSV
Solubility Soluble in DMSO
Appearance Solid powder
Storage Store at -20°C
IUPAC Name 1'-[[5-(aminomethyl)-1-(4,4,4-trifluorobutyl)benzimidazol-2-yl]methyl]-6'-fluorospiro[cyclopropane-1,3'-indole]-2'-one;hydrochloride
InChI InChI=1S/C23H22F4N4O.ClH/c24-15-3-4-16-19(11-15)31(21(32)22(16)7-8-22)13-20-29-17-10-14(12-28)2-5-18(17)30(20)9-1-6-23(25,26)27;/h2-5,10-11H,1,6-9,12-13,28H2;1H
InChIKey NYYYAFKAHRIPJW-UHFFFAOYSA-N
SMILES C1CC12C3=C(C=C(C=C3)F)N(C2=O)CC4=NC5=C(N4CCCC(F)(F)F)C=CC(=C5)CN.Cl
Reference

1: Cockerill GS, Angell RM, Bedernjak A, Chuckowree I, Fraser I, Gascon-Simorte J, Gilman MSA, Good JAD, Harland R, Johnson SM, Ludes-Meyers JH, Littler E, Lumley J, Lunn G, Mathews N, McLellan JS, Paradowski M, Peeples ME, Scott C, Tait D, Taylor G, Thom M, Thomas E, Villalonga Barber C, Ward SE, Watterson D, Williams G, Young P, Powell K. Discovery of Sisunatovir (RV521), an Inhibitor of Respiratory Syncytial Virus Fusion. J Med Chem. 2021 Mar 17. doi: 10.1021/acs.jmedchem.0c01882. Epub ahead of print. PMID: 33729773.
2: DeVincenzo J, Tait D, Efthimiou J, Mori J, Kim YI, Thomas E, Wilson L, Harland R, Mathews N, Cockerill S, Powell K, Littler E. A Randomized, Placebo- Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein. Antimicrob Agents Chemother. 2020 Jan 27;64(2):e01884-19. doi: 10.1128/AAC.01884-19. PMID: 31712214; PMCID: PMC6985722.

Request a Quote